Calida Therapeutics
About:
Calida Therapeutics operates as a biotechnology company.
Top Investors: AdBio partners
Description:
Calida Therapeutics operates as a biotechnology company. Calida Therapeutics develops monoclonal antibodies to treat and prevent thrombo-inflammatory disorders.
Total Funding Amount:
2M EUR
Headquarters Location:
Paris, Ile-de-France, France
Founded Date:
2022-01-01
Founders:
Dr. Daniel Simon.
Number of Employees:
1-10
Last Funding Date:
2023-04-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai